Literature DB >> 28770096

Italian validation of the Belastungsfragebogen Parkinson kurzversion (BELA-P-k): a disease-specific questionnaire for evaluation of the subjective perception of quality of life in parkinson's disease.

Paola Ortelli1, Roberto Maestri2, Marianna Zarucchi1, Veronica Cian1, Elisa Urso1, Francesca Giacomello1, Davide Ferrazzoli1, Giuseppe Frazzitta1.   

Abstract

BACKGROUND: Quality of life (QoL) is the sense of well-being perceived by people. The improvement of parkinsonian patient's QoL is a crucial goal for clinicians involved in rehabilitative care. In order to provide an appropriate endpoint for the assessment of the effectiveness of rehabilitation treatments on QoL of patients with Parkinson's Disease (PD), in this study we have first translated and then validated the Belastungsfragebogen Parkinson kurzversion (BELA-P-k). This tool allows evaluating separately two crucial aspects: i) the loss of personal autonomy in activities of daily life and ii) the psychological and psychosocial impact of the disease.
METHODS: The BELA-P-k was translated from Dutch into Italian. Subsequently 202 PD patients filled out the questionnaire. Patients were also evaluated by using the Parkinson Disease Questionnaire -39 (PDQ39), the Unified Parkinson's Disease Rating Scale (UPDRS), the Mini Mental State Examination (MMSE) and the Frontal Assessment Battery (FAB).
RESULTS: The internal consistency for total of two different scores Bothered by (Bb) and Need for Help (NfH) was excellent (p = 0.91) for both categories. The correlation between Bb and NfH categories was significant and strong, very-strong, ranging from 0.78 to 0.88 (all p < 0.0001). Finally, the value of Spearman r for the relationship between Bb and NfH items and PDQ 39 values were significant (p ≤ 0.003).
CONCLUSIONS: In conclusion, we validated the BELA-P-k and demonstrated that it is an appropriate and potentially useful tool for assessing QoL in the management of PD. TRIALS REGISTRATION: This trial was retrospectively registered with ClinicalTrials.gov, NCT03073044.

Entities:  

Keywords:  Quality of life; Rehabilitation treatment; Wellbeing

Year:  2017        PMID: 28770096      PMCID: PMC5525312          DOI: 10.1186/s40734-017-0059-x

Source DB:  PubMed          Journal:  J Clin Mov Disord        ISSN: 2054-7072


  26 in total

Review 1.  Assessing quality of life in clinical research: from where have we come and where are we going?

Authors:  S Wood-Dauphinee
Journal:  J Clin Epidemiol       Date:  1999-04       Impact factor: 6.437

2.  Measuring quality of life in Parkinson's disease: selection of-an-appropriate health-related quality of life instrument.

Authors:  Sze-Ee Soh; Jennifer McGinley; Meg E Morris
Journal:  Physiotherapy       Date:  2010-08-01       Impact factor: 3.358

3.  The Frontal Assessment Battery (FAB): normative values in an Italian population sample.

Authors:  I Appollonio; M Leone; V Isella; F Piamarta; T Consoli; M L Villa; E Forapani; A Russo; P Nichelli
Journal:  Neurol Sci       Date:  2005-06       Impact factor: 3.307

4.  How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population.

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  Mov Disord       Date:  2000-11       Impact factor: 10.338

5.  Influence of motor symptoms upon the quality of life of patients with Parkinson's disease.

Authors:  J C Gómez-Esteban; J J Zarranz; E Lezcano; B Tijero; A Luna; F Velasco; I Rouco; I Garamendi
Journal:  Eur Neurol       Date:  2007-01-10       Impact factor: 1.710

Review 6.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

7.  Quality of life in patients with Parkinson's disease: development of a questionnaire.

Authors:  A G de Boer; W Wijker; J D Speelman; J C de Haes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

8.  What contributes to quality of life in patients with Parkinson's disease?

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

9.  Determinants of health-related quality of life in people with Parkinson's disease: a path analysis.

Authors:  Sze-Ee Soh; Jennifer L McGinley; Jennifer J Watts; Robert Iansek; Anna T Murphy; Hylton B Menz; Frances Huxham; Meg E Morris
Journal:  Qual Life Res       Date:  2012-10-16       Impact factor: 4.147

Review 10.  Neurorehabilitation for Parkinson's disease: Future perspectives for behavioural adaptation.

Authors:  Merel S Ekker; Sabine Janssen; Jorik Nonnekes; Bastiaan R Bloem; Nienke M de Vries
Journal:  Parkinsonism Relat Disord       Date:  2015-09-08       Impact factor: 4.891

View more
  1 in total

1.  Efficacy of intensive multidisciplinary rehabilitation in Parkinson's disease: a randomised controlled study.

Authors:  Paola Ortelli; Roberto Maestri; Giuseppe Frazzitta; Davide Ferrazzoli; Ilaria Zivi; Veronica Cian; Elisa Urso; Maria Felice Ghilardi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-01-10       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.